drugset / Trial / NCT01754805

A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and Methotrexate in Patients With Rheumatoid Arthritis

NCT01754805

Phase 1 Completed 15 enrolled Astellas Pharma Inc
NaSingle-groupOpen-labelOther

Summary

A drug interaction study to evaluate the effect of ASP015K (twice daily) on the pharmacokinetics (PK) of once weekly oral methotrexate (MTX).

Timeline

Start
2010-01-22
Primary completion
2010-03-25
Completion
2010-03-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Methotrexate Small molecule 15 mg Oral
Subject Methotrexate Small molecule 25 mg Oral
Subject peficitinib Small molecule 100 mg Oral

Indications